Ads
related to: AstraZeneca- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Lab Products & Equipment
Shop our huge portfolio of labware
equipment from leading brands.
- Sigma® Life Science
Find cell culture, antibodies and
thousands of biological products
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Order Center
Build a Shopping Cart, View Orders
Access ordering instructions
- Sign In
Search results
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 10 hours agoImage source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q1 2024 Earnings Call Apr 25, 2024,...
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 13 hours agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...
AstraZeneca, Sanofi Bolt Higher On Quarterly Beats, But Bristol Myers Dives
Investor's Business Daily· 9 hours agoThe Cambridge U.K.-based drugmaker reported almost $5.11 billion in sales of its cancer drugs. Sales...
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 12 hours agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance via AOL· 7 hours agoAstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company...
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 9 hours agoAstraZeneca’s AZN first-quarter 2024 core earnings of $1.03 per American depositary share (ADS) beat...
What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?
Guru Focus· 8 hours agoAstraZeneca PLC (AZN, Financial) has recently seen a notable uptick in its stock performance, with a market capitalization now standing at a robust $231.04 billion. Over the ...
AstraZeneca Earnings, Sales Rise, Beat Forecasts
The Wall Street Journal· 17 hours agoHEALTH AstraZeneca posted increased first-quarter core earnings per share and sales that beat forecasts. The Anglo-Swedish pharmaceutical giant said...
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
BioPharma Dive via Yahoo Finance· 13 hours agoAstraZeneca’s revenue and profits grew at a rapid clip over the first three months of the year,...
AstraZeneca leaps after smashing first-quarter forecasts
Reuters via AOL· 21 hours agoAstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by...